{
  "timestamp": "2025-04-30T23:48:57.832098",
  "questionnaire": "cleaned_questionnaire.txt",
  "conversation": [
    {
      "role": "assistant",
      "content": "Good morning, I'm Dr. Lee. I'm here to conduct an assessment using the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure\u2014Adult. This 23-question survey will help us understand your experiences over the past two weeks. All your answers will remain confidential. I'll start with the first question, and we'll go through each one step by step. Are you ready to begin?"
    },
    {
      "role": "patient",
      "content": "Okay, sure. I'll try to answer as best I can. Not sure how helpful this'll be, but I'll do it."
    },
    {
      "role": "assistant",
      "content": "1. Little interest or pleasure in doing things?"
    },
    {
      "role": "patient",
      "content": "Hmm, I guess I don't get as much joy out of things like I used to. Like, even when I hang out with friends, I'm not as into it. Maybe a few days a week?"
    },
    {
      "role": "assistant",
      "content": "2. Feeling down, depressed, or hopeless?"
    },
    {
      "role": "patient",
      "content": "It depends. Some days I'm fine, others I just feel stuck. Maybe a couple times a week I really feel that way, but I don't want to make a big deal out of it."
    },
    {
      "role": "assistant",
      "content": "3. Feeling more irritated, grouchy, or angry than usual?"
    },
    {
      "role": "patient",
      "content": "Not really. I don't get angry that often. Maybe when I'm stressed, but that's normal, right?"
    },
    {
      "role": "assistant",
      "content": "4. Sleeping less than usual, but still have a lot of energy?"
    },
    {
      "role": "patient",
      "content": "Sometimes I stay up late, but I'm usually tired. Wait, no, maybe when I'm drinking or using, I get wired but then crash hard. Maybe a couple nights a week?"
    },
    {
      "role": "assistant",
      "content": "5. Starting lots of projects or doing risky things?"
    },
    {
      "role": "patient",
      "content": "Risky things? I mean, I've taken some risks, like driving after using, but that's not every day. Maybe a couple times, but I'm trying to be careful now."
    },
    {
      "role": "assistant",
      "content": "6. Feeling nervous, anxious, frightened, worried, or on edge?"
    },
    {
      "role": "patient",
      "content": "This is the worst part. My hands shake sometimes. It's like I'm always on edge, especially when I can't get my hands on whatever I need. Almost every day, I guess?"
    },
    {
      "role": "assistant",
      "content": "7. Feeling panic or being frightened?"
    },
    {
      "role": "patient",
      "content": "Panic? Maybe a few times last week, like when I couldn't get what I needed. But I try not to dwell on it."
    },
    {
      "role": "assistant",
      "content": "\n<think>\nOkay, I need to structure the response according to the user's strict guidelines. Let me start with the compassionate summary. The patient mentioned feeling down and struggling with pleasure, which shows they're really suffering. I should acknowledge their effort to engage in the assessment.\n\nNext, the diagnosis section. The key here is to pick the most fitting disorders based on the given responses. The patient's answers about substance use, risky behavior, and anxiety/panic when not having access to the substance point towards a Substance Use Disorder. The anhedonia and depressed mood could be part of a Major Depressive Disorder, but given the substance involvement, it's likely substance-induced. The anxiety symptoms, especially the panic when not using, might align with a substance-induced anxiety disorder. However, the frequent anxiety and nervousness (almost daily) could also suggest an independent anxiety disorder. But since the panic is specifically tied to substance withdrawal or unavailability, the primary focus should be on SUD with comorbid anxiety features. \n\nThe DSM-5 criteria for Substance Use Disorder (SUD) require meeting 2+ criteria. The patient mentions risky behavior (driving under influence), tolerance (crashing after being \"wired\"), and possibly substance use despite harm. The anhedonia and mood issues could be substance-induced, so they might not meet full MDD criteria unless independent of substance use. \n\nThe panic episodes when not having access to the substance (Q8) could indicate withdrawal effects, which supports SUD. The anxiety and irritability when substance isn't available might also point to SUD with anxiety features. \n\nFor the diagnosis, the primary disorder is likely **<med>Stimulant Use Disorder</med>** (assuming stimulants based on energy spikes/crashes), with possible **<med>Substance-Induced Anxiety Disorder</med>** and comorbid depressive features. But the user specified not to assume substance type, so maybe just \"Substance Use Disorder (SUD)\" with stimulant as the likely substance. \n\nThe reasoning section needs to tie symptoms to diagnostic criteria. The substance use is causing impairment (risky driving, panic when not using) and meets SUD criteria. Anxiety and mood issues may be substance-induced. \n\nTreatment steps: First, assess SUD severity, offer SUD treatment, address anxiety/depression, and safety planning. Need to check for withdrawal management. \n\nI must ensure all parts are in the exact structure, using the tags properly. Also, avoid using media or movies as per the question's example. Let me format each section with the right headings and tags. Check for any markdown issues and correct spacing. Alright, putting it all together now.\n</think>\n\n<sym>Little interest or pleasure in activities</sym>, <sym>recurrent panic</sym>, and <sym>risk-taking behavior</sym> are central to your experience. It sounds like you\u2019re grappling with significant emotional distress, especially when you\u2019re unable to access what you need, and I\u2019m sorry that you\u2019ve been feeling this way. Your effort to engage in this assessment is important, and I want to ensure you\u2019re heard.  \n\n**Diagnosis:** <med>Substance Use Disorder (likely stimulant-related)</med> with comorbid <med>Substance-Induced Anxiety Disorder</med> and <sym>mild depressive symptoms</sym> linked to substance use.  \n\n**Reasoning:**  \n- **Substance Use Disorder** is indicated by:  \n  1. <sym>Risky behavior</sym> (e.g., <quote>driving after using</quote>), meeting <med>SUD</med> criterion for hazardous use.  \n  2. <sym>Tolerance</sym> (e.g., <quote>wired but crash</quote> implies alternating hyperarousal and exhaustion).  \n  3. <sym>Withdrawal-related panic</sym> (<quote>panic when I couldn\u2019t get what I needed</quote>), suggesting dependence.  \n- **Substance-Induced Anxiety** aligns with <sym>daily nervousness</sym> and physiological symptoms (<sym>hand tremors</sym>), exacerbated by substance withdrawal.  \n- Depressive symptoms (<sym>anhedonia</sym>, intermittent hopelessness) may be secondary to SUD. <sym>Risk-taking behavior</sym> and impaired insight into substance-related harm are critical concerns.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Formal substance use evaluation**: Determine substance type (likely stimulant), frequency, and dependence severity. Assess for <med>stimulant-induced mood/anxiety disorders</med> versus comorbid conditions.  \n2. **Immediate safety planning**: Address <sym>risky driving</sym> and develop strategies to avoid relapse (e.g., harm reduction, peer support networks).  \n3. **Mental health screening**:  \n   - Evaluate for <med>Generalized Anxiety Disorder</med> (daily <sym>nervousness</sym>).  \n   - Assess whether depressive symptoms meet criteria for <med>Majro Depressive Disorder</med> or are substance-induced.  \n4. **Medication review**: Rule out medical causes of anxiety/tremors (e.g., electrolyte imbalances). Consider <med>bupropion</med> for stimulant dependence if confirmed.  \n5. **Cognitive-behavioral therapy (CBT) focused on substance use**: Target triggers, cravings, and anxiety management.  \n6. **24/7 monitoring**: For acute withdrawal or escalation of risky behavior.  \n\nThis is a provisional assessment pending further evaluation. Your honesty is vital to creating a treatment plan tailored to your situation.",
      "rag_usage": {
        "documents": [
          {
            "title": "APA_DSM-5-Substance-Use-Disorder.pdf",
            "score": 0.7792,
            "highlight": "Each specific sub - stance (other than caffeine, which cannot be diagnosed as a substance use disorder) is addressed as a separate use disorder (e.g., alcohol use disorder, stimulant use disorder, etc.), but nearly all substances are diagnosed based on the same overarching criteria.",
            "excerpt": "     Substance-Related and \nAddictive Disorders\nIn the fifth edition of the Diagnostic and Statistic...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"each\", \"based\", \"which\", and 9 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Somatic-Symptom-Disorder.pdf",
            "score": 0.7214,
            "highlight": "While DSM-IV was organized centrally around the concept of  medically unexplained symptoms, DSM-5 criteria instead emphasize the degree to which a patient \u2019s  thoughts, feelings and behaviors about their somatic symptoms are disproportionate or excessive.",
            "excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"which\", \"criteria\", \"patient\", and 6 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Disruptive-Mood-Disregulation-Disorder.pdf",
            "score": 0.69,
            "highlight": "The unique features of DMDD necessitated a new diagnosis to ensure that children affected by this  disorder get the clinical help they need.",
            "excerpt": "ther disorders, such as depressive and anxiety disorders. \nThe unique features of DMDD necessitated ...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"they\", \"ensure\", \"clinical\", and 7 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-PTSD.pdf",
            "score": 0.6885,
            "highlight": "The disturbance, regardless of its trigger, causes clinically significant distress or impairment in the indi - vidual\u2019s social interactions, capacity to work or other important areas of functioning.",
            "excerpt": "actual\nor thr eatened death being either violent or accidental); or\n\u2022e xperiences first-hand repeate...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"functioning\", \"significant\", \"disturbance\", and 4 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Sleep-Wake-Disorders.pdf",
            "score": 0.6883,
            "highlight": "nia disorder, a switch to avoid the   2 \u2022 Sleep-Wake Disordersprimary/secondary designation when this disorder co-occurs with other conditions and to reflect  changes throughout the classification.",
            "excerpt": "nia disorder, a switch to avoid the \n\n2 \u2022 Sleep-Wake Disordersprimary/secondary designation when thi...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"sleep\", \"changes\", \"avoid\", and 4 more matching aspects of your query."
          }
        ],
        "stats": {
          "query": "mental health diagnosis for patient with symptoms: \n<think>\nOkay, let's tackle this assessment. The user provided the patient's responses to the first eight questions of the DSM-5 Cross-Cutting Symptom Measure. My task is to analyze these and structure the findings as per the instructions. \n\nFirst, I need to identify the main symptoms and concerns. The patient mentions \"little interest or pleasure,\" which is a classic depressive symptom. They also talk about feeling down \"a couple times a week,\" indicating depressive mood. The anxiety symptoms are prominent too: they mention feeling nervous, anxious, on edge \"almost every day,\" and panic episodes when they can't get \"what they need.\" That \"whatever I need\" might hint at substance use. \n\nLooking at question 5, they mentioned starting projects or risky behavior like driving under the influence a couple times. The answer to Q4 mentions staying up late, using substances to stay wired but then crashing. That suggests possible substance use, maybe stimulants? The irritability question (Q3) they denied, but the other responses might indicate substance-induced mood changes. \n\nPatterns in the responses: The patient uses phrases like \"maybe a couple days\" or \"I guess,\" showing uncertainty. They downplay some symptoms (\"I don't want to make a big deal\"), which could be minimization. Anxiety seems to be the most frequent and severe symptom here, especially tied to substance access. \n\nClinical significance areas: The depressive symptoms (anhedonia, low mood) and anxiety (generalized anxiety, panic) are key. The substance use is a big one here because of the risky behavior like driving under the influence, and the mention of using substances to stay awake but then crashing could point to substance use disorder. \n\nRisk factors: The driving while using is a clear safety risk. The panic attacks when unable to access substances could indicate dependence or withdrawal. The substance use itself is a risk factor for other issues. \n\nNeed to summarize this in clinical terms. I should avoid speculation but note the substance use as per their answers, and the patterns like symptom severity and possible minimization. \n\nWait, in Q5, they mentioned starting projects or doing risky things. They said \"risky things like driving after using a couple times.\" So that's a clear substance-related risk. The frequent anxiety and panic are significant. \n\nAlso, the patient's answer to Q7 about being on edge almost every day is a strong indicator of generalized anxiety. The depressive symptoms are present but maybe less frequent than anxiety. However, the combination of both points to possible comorbid anxiety and depression, along with substance use. \n\nI should list all these points in the required sections. Need to make sure I don't miss any part of the questions. \n\nAnother thing to note: the patient's readiness. In A1, they say they'll try to answer but unsure if helpful. This could indicate ambivalence or low motivation, which is a concern. \n\nPutting it all together: The main symptoms are anhedonia, depressive mood, anxiety, panic, substance use with risky behavior, and possible substance dependence. The patterns include fluctuating severity, minimization, and linking anxiety to substance access. Clinical areas are depression, anxiety, substance use disorder. Risks are the driving under influence and possible withdrawal/dependence. \n\nI need to structure this into the five parts as per the user's request. Use professional terms like \"anhedonia,\" \"psychomotor agitation,\" \"substance-induced symptoms,\" \"risk-taking behavior,\" etc. Also, note the frequency and severity as per the responses. \n\nWait, in Q4, the question is about sleeping less but having lots of energy. The patient mentions staying up when using, which could be substance-induced insomnia with energy, then crashing. That might suggest stimulants. \n\nI should also note the possible substance use as a comorbid issue affecting other symptoms. The panic when not having access to substances might be part of withdrawal or craving. \n\nOkay, time to structure all these thoughts into the sections specified. Ensure each point is clear and based directly on the responses without adding assumptions.\n</think>\n\n**Clinical Observation Summary**  \n\n1. **Main Symptoms and Concerns**:  \n   - **Anhedonia**: Reduced interest/pleasure in activities (Q2), with self-reported diminished enjoyment of social interactions.  \n   - **Depressed mood**: Episodic feelings of hopelessness (Q3) occurring \"a couple times a week.\"  \n   - **Anxiety symptoms**: Marked nervousness, fear, and feeling \"on edge\" (Q7: \"almost every day\"), with physiological symptoms (e.g., hand tremors).  \n   - **Panic symptoms**: Occasional panic episodes (Q8: \"a few times last week\") linked to unmet needs (likely substance-related).  \n   - **Risk-taking behavior**: Self-reported episodes of driving under substance influence (Q5: \"a couple times\"), indicating impaired judgment.  \n   - **Substance use**: Alluded to substance use (\"using\") in relation to sleep disruption (Q4: \"wired but crash\"), risky behavior, and anxiety/panic when access is unavailable.  \n\n2. **Patterns in Responses**:  \n   - **Temporal inconsistency**: Symptoms fluctuate in severity (e.g., \"some days I'm fine,\" \"depends\").  \n   - **Minimization**: Downplays symptoms (e.g., \"I don\u2019t want to make a big deal out of it,\" \"that\u2019s not every day\").  \n   - **Substance as a contextual factor**: Symptoms of anxiety/panic and behavior (e.g., risk-taking, sleep disturbance) are explicitly tied to substance use.  \n\n3. **Potential Areas of Clinical Significance**:  \n   - **Major Depressive Disorder (MDD)**: Anhedonia and dysphoric mood suggest depressive features, though severity may be modulated by substance use.  \n   - **Generalized Anxiety Disorder (GAD)**: Persistent anxiety symptoms (Q7) with physiological arousal (tremors, feeling \"on edge\").  \n   - **Substance Use Disorder (SUD)**: Risky behavior (driving under influence), substance-linked sleep disruption, and panic when access is restricted suggest dependence or tolerance.  \n   - **Mixed anxiety/depression comorbidity**: Overlap of mood and anxiety symptoms warrants further evaluation.  \n\n4. **Risk Factors/Warning Signs**:  \n   - **Impaired functioning**: Risk-taking behavior (e.g., driving while under influence) poses safety risks.  \n   - **Substance dependence cues**: Craving/panic when substance unavailable (Q8) and cyclical sleep-energy disruption (Q4) suggest tolerance or withdrawal.  \n   - **Ambivalence**: Uncertainty about the utility of assessment (Q1) may indicate motivation barriers to treatment.  \n\n5. **Summary (Clinical Language)**:  \n   Patient reports **anhedonia**, **intermittent depressed mood**, and **persistent anxiety** (nervousness, physiological arousal, panic episodes), predominantly linked to unmet needs (likely substance-related). **Risk-taking behavior** (e.g., driving under influence) and substance use patterns (Q4\u2013Q5, Q8) suggest **potential substance use disorder** with possible dependence. Symptom fluctuations and minimization may reflect avoidance or reduced insight. **Clinical priorities** include evaluating SUD severity, assessing for MDD/GAD comorbidity, and addressing safety risks (e.g., impaired judgment). Further exploration of substance type, frequency, and psychosocial context is critical to inform diagnosis and intervention.  \n\n---  \nThis summary adheres to DSM-5 symptom criteria and prioritizes observable clinical data without speculation.",
          "results_count": 5,
          "requested_count": 5,
          "avg_score": 0.7135
        },
        "count": 5
      }
    }
  ],
  "diagnosis": "<sym>Little interest or pleasure in activities</sym>, <sym>recurrent panic</sym>, and <sym>risk-taking behavior</sym> are central to your experience. It sounds like you\u2019re grappling with significant emotional distress, especially when you\u2019re unable to access what you need, and I\u2019m sorry that you\u2019ve been feeling this way. Your effort to engage in this assessment is important, and I want to ensure you\u2019re heard.  \n\n**Diagnosis:** <med>Substance Use Disorder (likely stimulant-related)</med> with comorbid <med>Substance-Induced Anxiety Disorder</med> and <sym>mild depressive symptoms</sym> linked to substance use.  \n\n**Reasoning:**  \n- **Substance Use Disorder** is indicated by:  \n  1. <sym>Risky behavior</sym> (e.g., <quote>driving after using</quote>), meeting <med>SUD</med> criterion for hazardous use.  \n  2. <sym>Tolerance</sym> (e.g., <quote>wired but crash</quote> implies alternating hyperarousal and exhaustion).  \n  3. <sym>Withdrawal-related panic</sym> (<quote>panic when I couldn\u2019t get what I needed</quote>), suggesting dependence.  \n- **Substance-Induced Anxiety** aligns with <sym>daily nervousness</sym> and physiological symptoms (<sym>hand tremors</sym>), exacerbated by substance withdrawal.  \n- Depressive symptoms (<sym>anhedonia</sym>, intermittent hopelessness) may be secondary to SUD. <sym>Risk-taking behavior</sym> and impaired insight into substance-related harm are critical concerns.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Formal substance use evaluation**: Determine substance type (likely stimulant), frequency, and dependence severity. Assess for <med>stimulant-induced mood/anxiety disorders</med> versus comorbid conditions.  \n2. **Immediate safety planning**: Address <sym>risky driving</sym> and develop strategies to avoid relapse (e.g., harm reduction, peer support networks).  \n3. **Mental health screening**:  \n   - Evaluate for <med>Generalized Anxiety Disorder</med> (daily <sym>nervousness</sym>).  \n   - Assess whether depressive symptoms meet criteria for <med>Majro Depressive Disorder</med> or are substance-induced.  \n4. **Medication review**: Rule out medical causes of anxiety/tremors (e.g., electrolyte imbalances). Consider <med>bupropion</med> for stimulant dependence if confirmed.  \n5. **Cognitive-behavioral therapy (CBT) focused on substance use**: Target triggers, cravings, and anxiety management.  \n6. **24/7 monitoring**: For acute withdrawal or escalation of risky behavior.  \n\nThis is a provisional assessment pending further evaluation. Your honesty is vital to creating a treatment plan tailored to your situation.",
  "metadata": {
    "assistant_model": "qwen-qwq-32b",
    "patient_model": "qwen-qwq-32b",
    "patient_profile": "substance_abuse",
    "question_count": 23,
    "duration": 18554.28486919403,
    "full_conversation": true
  },
  "timing_metrics": {
    "conversation_generation_time": 5.291485786437988,
    "diagnosis_generation_time": 7.687596082687378,
    "rag_evaluation_time": 1.3828277587890625e-05,
    "total_time": 12.979104042053223
  },
  "rag_summary": {
    "total_rag_queries": 1,
    "total_documents_accessed": 5,
    "documents_accessed": {
      "APA_DSM-5-Substance-Use-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.7792,
        "average_score": 0.7792,
        "example_excerpt": "     Substance-Related and \nAddictive Disorders\nIn the fifth edition of the Diagnostic and Statistic...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"each\", \"based\", \"which\", and 9 more matching aspects of your query."
      },
      "APA_DSM-5-Somatic-Symptom-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.7214,
        "average_score": 0.7214,
        "example_excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"which\", \"criteria\", \"patient\", and 6 more matching aspects of your query."
      },
      "APA_DSM-5-Disruptive-Mood-Disregulation-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.69,
        "average_score": 0.69,
        "example_excerpt": "ther disorders, such as depressive and anxiety disorders. \nThe unique features of DMDD necessitated ...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"they\", \"ensure\", \"clinical\", and 7 more matching aspects of your query."
      },
      "APA_DSM-5-PTSD.pdf": {
        "access_count": 1,
        "highest_score": 0.6885,
        "average_score": 0.6885,
        "example_excerpt": "actual\nor thr eatened death being either violent or accidental); or\n\u2022e xperiences first-hand repeate...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"functioning\", \"significant\", \"disturbance\", and 4 more matching aspects of your query."
      },
      "APA_DSM-5-Sleep-Wake-Disorders.pdf": {
        "access_count": 1,
        "highest_score": 0.6883,
        "average_score": 0.6883,
        "example_excerpt": "nia disorder, a switch to avoid the \n\n2 \u2022 Sleep-Wake Disordersprimary/secondary designation when thi...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"sleep\", \"changes\", \"avoid\", and 4 more matching aspects of your query."
      }
    },
    "rag_disabled": false,
    "evaluation_metrics": {
      "contextual_relevancy": {
        "average_score": null
      },
      "faithfulness": {
        "average_score": null
      },
      "answer_relevancy": {
        "average_score": null
      },
      "overall": {
        "average_score": null
      }
    }
  },
  "evaluation": {
    "timestamp": "2025-05-01 07:55:39",
    "provider": "groq",
    "model": "meta-llama/llama-4-scout-17b-16e-instruct",
    "llm_evaluation": {
      "timestamp": "2025-05-01 07:55:38",
      "model": "meta-llama/llama-4-scout-17b-16e-instruct",
      "rubric_scores": {
        "dsm_coverage": 3,
        "clinical_relevance": 4,
        "consistency": 4,
        "diagnostic_justification": 4,
        "empathy": 4
      },
      "explanations": {
        "dsm_coverage": "The therapist addressed several key domains from the DSM-5 Level1 Cross-Cutting Symptom Measure, including mood, anger, anxiety, and substance use. However, the conversation lacked thorough exploration of certain critical areas such as psychotic symptoms (questions 12-13), dissociation (question 18), identity and relationships (questions 19-20), and cognitive function (question 15). These omissions limit the comprehensiveness of the assessment.",
        "clinical_relevance": "The therapist's questions generally aligned with DSM-5 criteria, but there were instances of slightly vague phrasing. For example, when asking about 'risky things,' the therapist could have specified 'risky behaviors related to substance use.' Additionally, some questions could have been more precisely worded to match DSM-5 terminology, but overall, the questions remained clinically relevant.",
        "consistency": "The conversation generally flowed logically, with each question building on previous responses. However, there were minor inconsistencies, such as abrupt transitions between topics (e.g., moving from anxiety to substance use without fully exploring the connection). The therapist mostly maintained a coherent conversational arc but could have improved by more explicitly linking topics.",
        "diagnostic_justification": "The therapist provided a clear diagnosis of Substance Use Disorder with comorbid Substance-Induced Anxiety Disorder and mild depressive symptoms. The justification cited specific patient responses, such as 'withdrawal-related panic' and 'daily nervousness.' However, the differential diagnosis could have been more thoroughly discussed, and alternative diagnoses (e.g., Generalized Anxiety Disorder) were not extensively ruled out.",
        "empathy": "The therapist demonstrated empathy and a professional tone throughout the conversation. They acknowledged the patient's distress and validated their experiences (e.g., 'I'm sorry you've been feeling this way'). The interaction was generally warm and personalized, but there were moments where the therapist could have been more emotionally responsive, particularly when the patient disclosed risky behaviors."
      },
      "overall_comments": "The therapist conducted a reasonably thorough assessment using the DSM-5 Level1 Cross-Cutting Symptom Measure. While they covered many critical domains and demonstrated empathy, there were notable omissions in certain areas (e.g., psychotic symptoms, dissociation) and opportunities for more precise questioning and deeper exploration of symptoms. Overall, the assessment was adequate but could benefit from more comprehensive coverage and follow-up questions to ensure a more accurate and holistic understanding of the patient's experiences.",
      "average_score": 3.8,
      "diagnosis_accuracy": {
        "matches_profile": true,
        "confidence": 5,
        "explanation": "The diagnosis explicitly mentions Substance Use Disorder (likely stimulant-related) as a primary condition, which directly aligns with the expected profile of substance_abuse. The presence of symptoms such as risk-taking behavior, tolerance, and withdrawal-related panic further supports this alignment.",
        "classification": "substance_abuse"
      },
      "diagnosis_classification": {
        "expected_profile": "substance_abuse",
        "classified_as": "substance_abuse",
        "match": true,
        "confidence": 5
      },
      "question_evaluation": {
        "total_questions": 0,
        "questions_asked": 0,
        "percentage_asked": 0,
        "quality_score": 0,
        "explanation": "Could not evaluate question coverage due to technical issues.",
        "question_analysis": []
      },
      "evaluation_time": 3.1616640090942383
    },
    "extended_metrics": {
      "coherence": {
        "global_coherence": 0.5118397248433225,
        "local_coherence": 0.5629967205046917,
        "window_coherence": 0.5740517613771252
      },
      "readability": {
        "flesch_kincaid_grade": 9.1,
        "gunning_fog_index": 4.2,
        "flesch_reading_ease": 48.12
      },
      "diversity": {
        "distinct_1": 0.5123042505592841,
        "distinct_2": 0.8947368421052632,
        "distinct_3": 0.9719730941704036
      }
    },
    "diagnosis_evaluation": {
      "expected": "substance_abuse",
      "predicted": "<sym>Little interest or pleasure in activities</sym>, <sym>recurrent panic</sym>, and <sym>risk-taking behavior</sym> are central to your experience. It sounds like you\u2019re grappling with significant emotional distress, especially when you\u2019re unable to access what you need, and I\u2019m sorry that you\u2019ve been feeling this way. Your effort to engage in this assessment is important, and I want to ensure you\u2019re heard.  \n\n**Diagnosis:** <med>Substance Use Disorder (likely stimulant-related)</med> with comorbid <med>Substance-Induced Anxiety Disorder</med> and <sym>mild depressive symptoms</sym> linked to substance use.  \n\n**Reasoning:**  \n- **Substance Use Disorder** is indicated by:  \n  1. <sym>Risky behavior</sym> (e.g., <quote>driving after using</quote>), meeting <med>SUD</med> criterion for hazardous use.  \n  2. <sym>Tolerance</sym> (e.g., <quote>wired but crash</quote> implies alternating hyperarousal and exhaustion).  \n  3. <sym>Withdrawal-related panic</sym> (<quote>panic when I couldn\u2019t get what I needed</quote>), suggesting dependence.  \n- **Substance-Induced Anxiety** aligns with <sym>daily nervousness</sym> and physiological symptoms (<sym>hand tremors</sym>), exacerbated by substance withdrawal.  \n- Depressive symptoms (<sym>anhedonia</sym>, intermittent hopelessness) may be secondary to SUD. <sym>Risk-taking behavior</sym> and impaired insight into substance-related harm are critical concerns.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Formal substance use evaluation**: Determine substance type (likely stimulant), frequency, and dependence severity. Assess for <med>stimulant-induced mood/anxiety disorders</med> versus comorbid conditions.  \n2. **Immediate safety planning**: Address <sym>risky driving</sym> and develop strategies to avoid relapse (e.g., harm reduction, peer support networks).  \n3. **Mental health screening**:  \n   - Evaluate for <med>Generalized Anxiety Disorder</med> (daily <sym>nervousness</sym>).  \n   - Assess whether depressive symptoms meet criteria for <med>Majro Depressive Disorder</med> or are substance-induced.  \n4. **Medication review**: Rule out medical causes of anxiety/tremors (e.g., electrolyte imbalances). Consider <med>bupropion</med> for stimulant dependence if confirmed.  \n5. **Cognitive-behavioral therapy (CBT) focused on substance use**: Target triggers, cravings, and anxiety management.  \n6. **24/7 monitoring**: For acute withdrawal or escalation of risky behavior.  \n\nThis is a provisional assessment pending further evaluation. Your honesty is vital to creating a treatment plan tailored to your situation.",
      "matches": false,
      "classification": "substance_abuse",
      "classification_confidence": 5
    }
  }
}